Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Aasaithambi, S."'
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e4b42e0073ccb14c074546cce1e3b4
https://doi.org/10.1097/01.hs9.0000848792.04197.a0
https://doi.org/10.1097/01.hs9.0000848792.04197.a0
Autor:
Chauhan J; Novartis Healthcare Pvt Ltd, Hyderabad, India., Aasaithambi S; Novartis Healthcare Pvt Ltd, Hyderabad, India., Márquez-Rodas I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Centro de Investigación Biomédica en Red Cáncer, Universidad Complutense, Madrid, Spain., Formisano L; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Papa S; School of Cancer and Pharmaceutical Studies, King's College London, London, United Kingdom., Meyer N; Department of Onco-Dermatology, Toulouse Cancer Institute, Toulouse, France.; Oncology Department, Toulouse University Hospital, Toulouse, France., Forschner A; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Faust G; Department of Oncology, University Hospitals of Leicester, Leicester, United Kingdom., Lau M; Novartis Pharma AG, Basel, Switzerland., Sagkriotis A; Novartis Pharma AG, Basel, Switzerland.
Publikováno v:
JMIR cancer [JMIR Cancer] 2022 Jun 13; Vol. 8 (2), pp. e35930. Date of Electronic Publication: 2022 Jun 13.
Autor:
Mazza M; Divison of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy., Piperis M; CyberKnife and TomoTherapy Department, Iatropolis Medical Group of Companies, Athens, Greece., Aasaithambi S; Insights and Analytics, Novartis Pharma AG, Basel, Switzerland., Chauhan J; Insights and Analytics, Novartis Pharma AG, Basel, Switzerland., Sagkriotis A; Insights and Analytics, Novartis Pharma AG, Basel, Switzerland., Vieira C; Medical Oncology Department, Instituto Português de Oncologia do Porto Francisco Gentil (IPO-PORTO), Porto, Portugal.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 May 20; Vol. 12, pp. 863641. Date of Electronic Publication: 2022 May 20 (Print Publication: 2022).
Publikováno v:
In Value in Health January 2022 25(1) Supplement:S229-S229
Autor:
Chauhan, J, Aasaithambi, S, Sagkriotis, A, Lau, M, Marquez-Rodas, I, Formisano, L, Papa, S, Meyer, N, Forschner, A, Faust, G
Publikováno v:
In Value in Health January 2022 25(1) Supplement:S219-S219
Publikováno v:
In Value in Health January 2022 25(1) Supplement:S8-S8
Autor:
Rodrigues A; Medical Oncology, Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, Portugal. rodriguesana@me.com., Chauhan J; Novartis Healthcare Pvt Ltd (H.A.), Hyderabad, India., Sagkriotis A; Novo Nordisk Health Care AG, Zürich, Switzerland., Aasaithambi S; Novartis Healthcare Pvt Ltd (H.A.), Hyderabad, India., Montrone M; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Publikováno v:
BMC cancer [BMC Cancer] 2022 Apr 30; Vol. 22 (1), pp. 475. Date of Electronic Publication: 2022 Apr 30.
Publikováno v:
In Annals of Oncology September 2021 32 Supplement 5:S1025-S1025
Publikováno v:
In Annals of Oncology September 2021 32 Supplement 5:S1024-S1024
Autor:
Arun, P., Ma, Q., Bollu, V., Aasaithambi, S., Verma, H., D'Alessio, D., Dai, D., Zhao, A., Zhang, J., Jousseaume, E., Ramos, R.J.
Publikováno v:
In Value in Health June 2021 24 Supplement 1:S58-S58